1. Home
  2. SIBN vs CTMX Comparison

SIBN vs CTMX Comparison

Compare SIBN & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SI-BONE Inc.

SIBN

SI-BONE Inc.

N/A

Current Price

$13.83

Market Cap

671.7M

Sector

Health Care

ML Signal

N/A

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

N/A

Current Price

$4.90

Market Cap

596.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SIBN
CTMX
Founded
2008
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
671.7M
596.2M
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
SIBN
CTMX
Price
$13.83
$4.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
7
Target Price
$24.13
$8.86
AVG Volume (30 Days)
512.4K
2.2M
Earning Date
05-14-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
41.33
N/A
EPS
N/A
N/A
Revenue
$67,301,000.00
$138,103,000.00
Revenue This Year
$16.89
N/A
Revenue Next Year
$14.95
N/A
P/E Ratio
N/A
$22.58
Revenue Growth
21.53
36.45
52 Week Low
$12.50
$0.40
52 Week High
$21.89
$6.35

Technical Indicators

Market Signals
Indicator
SIBN
CTMX
Relative Strength Index (RSI) 37.16 44.03
Support Level N/A $3.83
Resistance Level $17.05 $6.20
Average True Range (ATR) 0.75 0.32
MACD -0.09 -0.07
Stochastic Oscillator 21.39 17.65

Price Performance

Historical Comparison
SIBN
CTMX

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: